Cleared Traditional

K182074 - Mineral Collagen Composite Bioactive Moldable

K182074 is an FDA 510(k) clearance for Mineral Collagen Composite Bioactive Mo..., manufactured by Collagen Matrix, Inc.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 232-day FDA review.

K182074 · Collagen Matrix, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
232d
Days
Class 2
Risk

K182074 is an FDA 510(k) clearance for the Mineral Collagen Composite Bioactive Moldable. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Collagen Matrix, Inc. (Oakland, US). The FDA issued a Cleared decision on March 21, 2019 after a review of 232 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Collagen Matrix, Inc. devices

FDA 510(k) Submission Details - K182074

510(k) Number K182074 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2018
Decision Date March 21, 2019
Days to Decision 232 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d slower than avg
Panel avg: 122d · This submission: 232d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 401
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K182074.
AccuFill Bone Substitute Material
K190814 · Zimmer Knee Creations · Jun 2019
IGNITE Bone Void Filler
K190482 · Wrightmedicaltechnologyinc · May 2019
NanoBone SBX PUTTY, NanoBone QD
K190110 · Artoss GmbH · Apr 2019
PROSTIM Injectable Inductive Graft
K190283 · Wrightmedicaltechnologyinc · Mar 2019
FIBERGRAFT AERIDYAN Matrix Bone Graft Substitute
K182670 · Prosidyan, Inc. · Dec 2018
MagnetOs Putty
K181958 · Kuros Biosciences B.V · Dec 2018